INFERIOR OUTCOMES WITH POLATUZUMAB VEDOTIN, BENDAMUSTINE AND RITUXIMAB FOR TREATMENT OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA AFTER >1 PRIOR LINE OF THERAPY by Northend, M., Wilson, W., Ediriwickrema, K., Osborne, W., Auer, R., Burton, C., Davies, A., El‐Sharkawi, D., Fox, C., Karim, R., Kuhnl, A., McKay, P., Peng, Y. Y., Phillips, E., Phillips, N., Townsend, W.

Get full text

Clonal Dynamics and Deterministic Clinical Fate Mapping of Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukemia with TP53 Disruption by Patel, Shyam Ajay, Tanenbaum, Benjamin, Ediriwickrema, Asiri, Cerny, Jan, Hutchinson, Lloyd, Meng, Xiuling, Gerber, William K, Khedr, Salwa, Selove, William, Woda, Bruce, Gerber, Jonathan M.

Get full text

Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence‐Based Review with Recommendations by Roland, Lauren T., Humphreys, Ian M., Le, Christopher H., Babik, Jennifer M., Bailey, Christopher E., Ediriwickrema, Lilangi S., Fung, Monica, Lieberman, Joshua A., Magliocca, Kelly R., Nam, Hannah H., Teo, Neville W., Thomas, Penelope C., Winegar, Blair A., Birkenbeuel, Jack L., David, Abel P., Goshtasbi, Khodayar, Johnson, Patricia G., Martin, Elaine C., Nguyen, Theodore V., Patel, Neil N., Qureshi, Hannan A., Tay, Kaijun, Vasudev, Milind, Abuzeid, Waleed M., Hwang, Peter H., Jafari, Aria, Russell, Matthew S., Turner, Justin H., Wise, Sarah K., Kuan, Edward C.

Get full text

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions by Patel, Shyam A, Cerny, Jan, Gerber, William K, Ramanathan, Muthalagu, Ediriwickrema, Asiri, Tanenbaum, Benjamin, Hutchinson, Lloyd, Meng, Xiuling, Flahive, Julie, Barton, Bruce, Gillis-Smith, Andrew J, Suzuki, Sakiko, Khedr, Salwa, Selove, William, Higgins, Anne W, Miron, Patricia M, Simin, Karl, Woda, Bruce, Gerber, Jonathan M

Get full text

Adjuvant Systemic Therapy in High Risk Solitary Bone Plasmacytoma: Results of the UK Randomised Phase III IDRIS Study (CR UK/14/032) by Ediriwickrema, Kushani, Rabin, Neil K, D'Sa, Shirley, Jackson, Graham, Hoskin, Peter, Gallop-Evans, Eve, Diez, Patricia, Parbutt, Catherine, Lopes, Andre, Galani, Sevasti, Clifton-Hadley, Laura, Edwards, Darren, Timur Tezver, Husne, de Tute, Ruth M., Bates, Andrew, Owen, Roger G

Get full text

The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia by Nakauchi, Yusuke, Azizi, Armon, Thomas, Daniel, Corces, M Ryan, Reinisch, Andreas, Sharma, Rajiv, Cruz Hernandez, David, Köhnke, Thomas, Karigane, Daiki, Fan, Amy, Martinez-Krams, Daniel, Stafford, Melissa, Kaur, Satinder, Dutta, Ritika, Phan, Paul, Ediriwickrema, Asiri, McCarthy, Erin, Ning, Yuhong, Phillips, Tierney, Ellison, Christopher K, Guler, Gulfem D, Bergamaschi, Anna, Ku, Chin-Jen, Levy, Samuel, Majeti, Ravindra

Get full text